SVB Provides $3MM Secured Facility to OncoCyte

OncoCyte amended its loan and security agreement with Silicon Valley Bank pursuant to which Oncocyte obtained a new $3 million secured credit facility.

SVB Provides $10MM Revolver to Luna Innovations

Luna Innovations entered into a new $10 million revolving credit facility with Silicon Valley Bank.

Barclays, Citibank, Others Provide $154.4MM Revolver to Keywords Studios

Barclays Bank, Citibank, HSBC and Silicon Valley Bank provided a revolving credit facility of up to €140 million ($154.4 million) to Keywoods Studios.

Solar Capital, SVB Provide $10MM Term Loan for scPharmaceuticals

scPharmaceuticals completed a new $20 million term loan with Solar Capital and Silicon Valley Bank.

Oxford, SVB Expand Xeris Pharmaceuticals Facility to $85MM

Xeris Pharmaceuticals amended its loan and security agreement with Oxford Finance and Silicon Valley Bank, increasing the borrowing base from $45 million to up to $85 million.

Barclays, Citibank, Others Provide $155 Revolver for Keywords Studios

Keywords Studios closed a €140 million ($155 million) revolving credit facility with a bank group including Barclays, Citibank, HSBC and Silicon Valley Bank.

SVB Closes $6.4MM Venture Debt Financing with Kantox

UK-based fintech company Kantox closed its second venture debt financing deal with Silicon Valley Bank.

SVB Appoints New Leaders in Funds Management & Commercial Banking

SVB Financial Group, the parent company of Silicon Valley Bank, has appointed John China president of SVB Capital and Dave Sabow head of Technology Banking.

Silicon Valley Bank Arranges $55MM Financing for US HealthVest

Silicon Valley Bank led a $55 million senior secured term loan for US HealthVest, a developer and operator of behavioral health facilities. The financing included a $30 million first lien revolving line and term loan from SVB and a $25 million second lien term loan from a third party.

SVB, MidCap Financial Provide $100MM Facility to Organogenesis

SVB and MidCap Financial entered a $100 million credit agreement with Organogenesis, a regenerative medicine company focused on product solutions for the advanced wound care and surgical and sports medicine markets.